Impax Agrees To Buy Genetic Products For $586 Million
June 21, 2016 at 07:51 AM EDT
Impax Laboratories, Inc. (NASDAQ: IPXL) revealed Tuesday that it reached definitive agreements with Teva Pharmaceutical Industries ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.